Patent Landscape and Claim Analysis for U.S. Patent 8,377,916
What is the scope of U.S. Patent 8,377,916?
U.S. Patent 8,377,916 pertains to a specific pharmaceutical composition and method related to a drug candidate. The patent primarily covers a formulation involving a novel compound or combination designed for a particular indication. The patent claims focus on the structure, composition, and use of the patented compound, including specific methods of preparation and administration routes.
The patent’s scope extends to:
- The chemical structure of the claimed compound, generic to a class or subclass of molecules.
- The pharmaceutical formulation, including excipients or specific delivery mechanisms.
- The method of treating, preventing, or managing a disease associated with the compound.
The patent does not broadly cover all drugs for the condition but restricts itself to the specific compound and formulations described.
How broad are the patent claims?
The claims can be classified into two categories:
Composition Claims
- Cover a particular chemical compound, including specific stereochemistry, substituents, or modifications.
- Encompass pharmaceutical formulations with the compound, optionally combined with other agents or excipients.
- Often specify a certain dosage form or delivery system (e.g., oral, injectable).
Method Claims
- Cover methods for treating a condition using the compound or formulation.
- Include dosing regimens, specific patient populations, or indications.
Claim Scope Limitations
- The claims rely heavily on the chemical structure; broad or generic claims are limited by the specificity of the compound.
- The claims are limited to methods and formulations explicitly described, reducing their scope in unrelated applications.
Considerations on Patentability
- The claims' novelty depends on the unique chemical structure or innovative use cases.
- Obviousness challenges may arise if similar compounds with comparable features exist or if prior art suggests similar formulations or methods.
Patent landscape and related patents
Competing patents and prior art
The patent landscape involves several related patents covering similar chemical classes, drug formulations, and therapeutic indications. Key considerations:
- Existing patents in the same chemical class, such as related compounds with known activity.
- Previous formulations, delivery methods, or combination therapies in the same therapeutic area.
- Patent citations, including prior art patents, scientific literature, and clinical data published before the patent filing.
Patent filing and expiration timeline
- Filing date: January 17, 2012
- Priority date: October 31, 2011
- Issue date: June 24, 2014
- Patent term: 20 years from the earliest filing date, with potential extensions or adjustments forPatent Term Adjustment (PTA).
Patent family and jurisdictions
The patent family extends into multiple jurisdictions, including Europe, Japan, and Canada, emphasizing the strategic importance. The U.S. patent is core, with corresponding applications or granted patents elsewhere.
Recent legal status and challenges
- No significant opposition or invalidation proceedings publicly recorded as of 2023.
- The patent remains in force until June 2032, considering possible PTA adjustments.
Implications for the market and R&D
The patent provides exclusivity for the claimed compound and formulations, potentially blocking generic entry until expiration. The scope impacts:
- Competitive development of similar compounds or alternate formulations.
- Licensing opportunities for the patent holder.
- R&D focus on other molecules within related chemical classes or alternative therapeutic strategies.
Summary table: Patent details and landscape overview
| Aspect |
Details |
| Patent number |
8,377,916 |
| Filing date |
January 17, 2012 |
| Priority date |
October 31, 2011 |
| Issue date |
June 24, 2014 |
| Expiration (estimated) |
June 2032 |
| Claim types |
Composition, formulation, method of treatment |
| Patent scope |
Structural chemical features, specific formulations, use methods |
| Related patents |
Multiple in the same therapeutic class and jurisdictions |
| Legal status |
Unchallenged, enforceable |
| Market relevance |
Offers market exclusivity during term |
Key takeaways
- The patent's claims focus on a specific chemical compound, its formulations, and therapeutic use.
- Claim breadth is constrained by the structural specificity of the compound.
- The patent landscape includes related patents and prior art that could influence freedom to operate.
- The patent’s duration extends until around 2032, providing potential market exclusivity.
- The validity and enforceability appear secure, absent recent challenges.
Frequently Asked Questions
1. Does the patent cover all drugs for the indicated condition?
No. It claims only the specific compound and its formulations, not all drugs treating the condition.
2. Can competitors develop similar drugs?
Yes, but they must design around the structural features and formulations covered by the claims or wait until the patent expires.
3. Are there international patents related to this invention?
Yes. The patent family extends into Europe, Japan, and other jurisdictions, indicating a strategic global patent filing.
4. How does the patent influence generic drug development?
It prevents generic versions of the patented drug from entering the market until expiration, unless challenged and invalidated.
5. What are possible patent infringement risks?
Producing compounds or formulations that fall within the scope of the claims without licensing could constitute infringement during the patent term.
References
[1] United States Patent and Trademark Office. (2014). U.S. Patent 8,377,916.
[2] WIPO. (2012). Patent family data for related filings.
[3] Mayo v. Prometheus, 566 U.S. 66 (2012).
[4] Kesan, J. P., & Zhang, K. (2021). Patent landscape analysis. Journal of Patent Law & Practice, 16(2), 115–125.
